Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|February 10, 2024
Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft ModelsShoko Ueda, Tomohito Tanaka, Kensuke Hirosuna, et al.
International Journal of Molecular Sciences|December 23, 2022
Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell CarcinomaHiroshi Maruoka, Tomohito Tanaka, Hikaru Murakami, et al.
Journal of Clinical Medicine|May 11, 2024
Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early ExperienceRuri Nishie, Tomohito Tanaka, Kensuke Hirosuna, et al.
NPJ Precision Oncology|September 17, 2024
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinomaKazuki Nishimura, Kiyoshi Takahara, Kazumasa Komura, et al.
World Journal of Urology|February 18, 2020
Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohortTomohisa Matsunaga, Kazumasa Komura, Takeshi Hashimoto, et al.
BMC Cancer|February 28, 2021
Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~Takeshi Tsutsumi, Kazumasa Komura, Takeshi Hashimoto, et al.
Annals of Surgical Oncology|June 27, 2019
The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in JapanKazumasa Komura, Takeshi Hashimoto, Takuya Tsujino, et al.
Oncogene|September 21, 2021
Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agentsKazumasa Komura, Teruo Inamoto, Takuya Tsujino, et al.
Urologic Oncology|March 29, 2022
Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinomaTaizo Uchimoto, Ko Nakamura, Kazumasa Komura, et al.
Gynecologic Oncology|January 13, 2023
Evaluation of the one-step nucleic acid amplification assay for detecting lymph node metastasis in patients with cervical and endometrial cancer: A multicenter prospective studyShinichi Togami, Akihide Tanimoto, Shintaro Yanazume, et al.
Pageof 11